Each doubling of perfluoroheptanesulfonic acid linked to 9 and 17 percent higher risk for elevated BP at ages 6 to 12, 13 to 18 years, respectively, in male children
Each doubling of perfluoroheptanesulfonic acid linked to 9 and 17 percent higher risk for elevated BP at ages 6 to 12, 13 to 18 years, respectively, in male children